Jove
Visualize
お問い合わせ

関連する概念動画

Anatomy of the Heart01:27

Anatomy of the Heart

119.4K
The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
119.4K
Anatomy of the Heart01:20

Anatomy of the Heart

2.8K
The heart is a hollow, muscular organ approximately the size of a fist, consisting of four chambers. It is enclosed in the pericardium, a fibrous sac with two layers: the visceral and parietal pericardium, separated by a fluid-filled space containing serous fluid to reduce friction.
The heart has three layers: the innermost endocardium, the muscular myocardium, and the outer epicardium, all working together for optimal cardiac function.
Chambers of the Heart
The heart is made up of four...
2.8K
Overview of the Heart01:07

Overview of the Heart

13.0K
The heart, a muscular organ located in the chest, functions as the body's pump, circulating blood through the vascular system. It has four chambers: two atria on top and two ventricles below. The right atrium receives deoxygenated blood from the body and passes it to the right ventricle, which pumps it to the lungs for oxygenation. The left atrium receives oxygenated blood from the lungs and transfers it to the left ventricle, which pumps it to the rest of the body.
The heart's structure...
13.0K
Conduction System of the Heart01:19

Conduction System of the Heart

12.6K
Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
12.6K
Conduction System of the Heart01:20

Conduction System of the Heart

3.5K
The cardiac conduction system produces and transmits electrical impulses that prompt myocardial contraction, ensuring efficient heart function. This intricate system ensures that the heart beats in a coordinated and efficient manner, beginning with the atria and then the ventricles. The conduction system optimizes cardiac output by maintaining this precise sequence, which is crucial for adequate blood circulation.
This system relies on the unique properties of nodal and Purkinje cells:...
3.5K
Tissue Transplantation01:24

Tissue Transplantation

937
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
937
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー
  1. ホーム
  2. 心臓移植におけるドナーシンバスタチン治療
  1. ホーム
  2. 心臓移植におけるドナーシンバスタチン治療

関連する実験動画

Author Spotlight: Enhancing Donor Heart Preservation Through Isolated Rat Heart Perfusion Studies
06:56

Author Spotlight: Enhancing Donor Heart Preservation Through Isolated Rat Heart Perfusion Studies

Published on: October 4, 2024

952

心臓移植におけるドナーシンバスタチン治療

Antti I Nykänen1,2,3, Emil J Holmström1,3, Raimo Tuuminen1,3

  • 1Transplantation Laboratory (A.I.N., E.J.H., R.T., R.K., K.D., S.O.S., K.B.L.), University of Helsinki and Helsinki University Hospital, Finland.

Circulation
|July 30, 2019

PubMed で要約を見る

まとめ
この要約は機械生成です。

心臓移植前の臓器提供者にシンバスタチンを投与すると,受容者の心筋損傷のバイオマーカーが著しく減少します. この安全で安価な補助療法は 移植の結果を改善する見込みです

キーワード:
心臓移植血中不全リパルフュージョンスタチン

さらに関連する動画

A Modified Method for Heterotopic Mouse Heart Transplantion
11:29

A Modified Method for Heterotopic Mouse Heart Transplantion

Published on: June 23, 2014

13.1K
Optimization of the Cuff Technique for Murine Heart Transplantation
14:01

Optimization of the Cuff Technique for Murine Heart Transplantation

Published on: June 26, 2020

10.1K

関連する実験動画

Author Spotlight: Enhancing Donor Heart Preservation Through Isolated Rat Heart Perfusion Studies
06:56

Author Spotlight: Enhancing Donor Heart Preservation Through Isolated Rat Heart Perfusion Studies

Published on: October 4, 2024

952
A Modified Method for Heterotopic Mouse Heart Transplantion
11:29

A Modified Method for Heterotopic Mouse Heart Transplantion

Published on: June 23, 2014

13.1K
Optimization of the Cuff Technique for Murine Heart Transplantation
14:01

Optimization of the Cuff Technique for Murine Heart Transplantation

Published on: June 26, 2020

10.1K

科学分野:

  • 心臓病科
  • 移植医学
  • 薬理学について

背景:

  • 心臓移植の予後には悪影響を及ぼします.
  • 実験データによると,臓器提供者に投与されたシンバスタチンは血管保護を提供し,心臓アロ移植IRIを軽減します.

研究 の 目的:

  • 多臓器ドナーに投与されたシンバスタチンの心臓移植後の心筋損傷の軽減における有効性を評価する.

主な方法:

  • 84人の多臓器ドナーを対象としたランダム化試験で,そのうち42人が80 mgのシンバスタチンを受け,42人が対照群であった.
  • 主要エンドポイント: 24時間以内に受容者の血トロポニンTおよびIレベル.
  • 二次的エンドポイント: 血液動力学,炎症,アロ移植機能,拒絶,死亡率.

主要な成果:

  • 投与後の受給者のトロポニンT (34%) とトロポニンI (40%) が著しく低下した.
  • NT- proBNPの濃度低下 (36%) と血液動力学的な妥協による拒絶治療の減少 (53%) が観察されました.
  • ドナーの脂質に有意な影響はないが,受容者の心筋の遺伝子発現と炎症マーカー (CXCL10,IL- 1α) の低下は認められる.

結論:

  • ドナーシムバスタチンの投与は,心臓移植患者の心筋損傷のバイオマーカーを効果的に低下させる.
  • シムバスタチンは安全性により,多臓器提供における新規で費用対効果の高い補助療法として用いられる.